TIF
An educational leaflet with important information for β-thalassaemia patients on hematopoietic stem cell transplantation (HSCT), more commonly known as bone marrow transplantation (BMT).
Latest News:
- 34 year old Victoria Gray will be the first American to get controversial gene-editing treatment for sickle cell disease
- World Hepatitis Day 2019
- FDA Accelerates Review Of Sickle Cell Disease Medicine Crizanlizumab
- Drones Land in the Cell and Gene Therapy Space
- TIF and the UKTS set up an official thalassaemia training programme for Nepalese nurses
